Voquezna Shortage Update: What Patients Need to Know in 2026

Patients prescribed Voquezna (vonoprazan) are increasingly reporting the same frustrating experience: they take the prescription to the pharmacy, and the medication isn't in stock. So what's going on? Is there an official Voquezna shortage, or something else? Here's the most current information heading into 2026.

Is Voquezna Officially in Shortage?

No. As of 2026, Voquezna (vonoprazan) is not on the FDA's official drug shortage list. The FDA tracks genuine manufacturing shortages, and Voquezna doesn't have one. There is no disruption at Phathom Pharmaceuticals' supply chain, no ingredient shortage, and no regulatory hold.

The challenge patients face is different: Voquezna is a newer, brand-name-only drug that many retail pharmacies simply haven't built into their standard inventory. It was only approved as a standalone tablet in November 2023 — making it relatively new to the U.S. market. The combination packs (Triple Pak and Dual Pak) were approved earlier in May 2022 for H. pylori treatment.

Why Are Patients Still Having Trouble Getting Voquezna?

Even without an official shortage, access problems are real. Here's why:

• Limited retail pharmacy stocking. Because Voquezna is a high-cost brand-name drug (cash price ~$830–$1,013/month), many pharmacies don't carry it routinely unless there's a consistent patient base ordering it.

• Insurance prior authorization delays. Many insurers require a prior authorization (PA) before covering Voquezna, and some require step therapy — trying a generic PPI first. PA processes can take days to weeks.

• No generic equivalent. Without a generic, there's no low-cost fallback at most pharmacies. The patent isn't expected to expire until after 2030.

• Growing prescriptions, slower distribution catch-up. As more gastroenterologists and PCPs prescribe Voquezna — especially after Phathom's 2024 direct-to-consumer campaign — pharmacy distribution networks are still catching up.

What Is the Availability Outlook for Voquezna in 2026?

Availability is expected to gradually improve as pharmacy stocking catches up with prescribing volume. Voquezna has been added to major insurance formularies, including CVS Caremark (over 26 million commercial members) and Express Scripts. This broader coverage creates more incentive for pharmacies to stock it.

That said, patients in rural areas and those using smaller independent pharmacies may continue to face stocking challenges throughout 2026. Specialty pharmacy delivery (via BlinkRx) and mail-order options are the most reliable alternatives.

What Should You Do Right Now If You Can't Fill Your Voquezna Prescription?

1. Use medfinder. medfinder.com calls pharmacies near you to find which ones have Voquezna in stock. You get results by text without making a single call yourself.

2. Request BlinkRx delivery. Phathom Pharmaceuticals' delivery partner can ship Voquezna to your door. Ask your prescriber to e-prescribe to BlinkRx, or call 1-844-759-0782.

3. Contact your prescriber about prior auth. If your insurance is blocking coverage, your doctor can initiate the prior authorization process. BlinkRx also provides PA support.

4. Apply for the Voquezna Savings Card. If you have commercial insurance, visit voquezna.com/savings or call 1-833-366-7149 to enroll. Eligible patients can pay as little as $25 per prescription.

5. Ask about a PPI bridge. If Voquezna is going to take time to obtain, talk to your doctor about whether a generic PPI (omeprazole, lansoprazole, pantoprazole) is appropriate as a temporary bridge. Do not stop acid suppression therapy abruptly.

Will the Voquezna Availability Problem Get Better?

Yes — the trend is toward wider availability. Growing formulary coverage, Phathom's DTC marketing, and increased familiarity among pharmacists are all driving better stocking over time. The biggest single risk for a real shortage would be a sudden spike in prescriptions outpacing distribution capacity, but there are no signs of that as of early 2026.

The Bottom Line

There is no official Voquezna drug shortage in 2026, but availability challenges are real. The good news is that solutions exist — from specialty delivery to savings programs. Read more about why Voquezna is hard to find in our deeper explainer: Why Is Voquezna So Hard to Find?.